Article Details
Retrieved on: 2024-10-14 17:08:35
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses BARDA's collaboration with RedHill Biopharma to develop Opaganib as a treatment for Ebola, addressing the biopharma key concept by highlighting advancements in medical countermeasures for biodefense against zoonotic diseases like Ebola. It mentions relevant tags such as clinical trials, FDA involvement, and pharmaceutical collaboration to address Ebola virus challenges effectively.
Article found on: www.stocktitan.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here